Erectile dysfunction drugs allowed more chemotherapy to reach brain tumors in laboratory study

July 28, 2008

In a study using laboratory animals, researchers found that medications commonly prescribed for erectile dysfunction opened a mechanism called the blood-brain tumor barrier and increased delivery of cancer-fighting drugs to malignant brain tumors.

The experiments were conducted at Cedars-Sinai Medical Center's Maxine Dunitz Neurosurgical Institute and published in Brain Research.

Viagra (sildenafil) and Levitra (vardenafil) are known as PDE5 inhibitors because they block an enzyme, phosphodiesterase5, which interrupts a series of biochemical events that cause the decreased blood flow of erectile dysfunction. This laboratory rat study, published online ahead of print in the journal, found that similar biochemical interactions in the small vessels of the brain play a major role in the blood-brain tumor barrier, which impedes delivery of anti-tumor drugs into brain tumors. PDE5 inhibitors were found to open the barrier and increase drug transport in this early animal study.

Although the normal blood-brain barrier, which regulates access to the brain from the bloodstream, shares many characteristics with the blood-brain tumor barrier, the signaling mechanism blocked by PDE5 inhibitors is unique to the blood-brain tumor barrier. This allows the PDE5 inhibitors to selectively increase drug transport to malignant brain tumors without affecting normal brain tissue.

According to the researchers, these findings may have significant implications in improving drug delivery to brain tumors in patients.

"This is the first study to show that oral administration of PDE5 inhibitors increases the rate of transport of compounds across the blood-brain tumor barrier and improves the effectiveness of the anti-tumor drug adriamycin in the treatment of brain tumors in a rat model. We chose adriamycin for this study because it is one of the most effective drugs against brain tumor cell lines in the laboratory but it has very little effect in animals and humans because it is unable to cross the blood-brain tumor barrier. The combination of vardenafil and adriamycin resulted in longer survival and smaller tumor size," said neurosurgeon Keith L. Black, M.D., chairman of the Department of Neurosurgery at Cedars-Sinai Medical Center and director of the Maxine Dunitz Neurosurgical Institute.

Black, the article's first and corresponding author, has been recognized for his earlier groundbreaking work to break through the blood-brain tumor barrier with natural and synthetic bradykinin, a peptide that temporarily opens the barrier and increases anti-cancer drug delivery into certain tumors by more than 1,000 percent. In 2000, he received the Javits Neuroscience Investigator Award from the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health, for his blood-brain barrier research.

In the current studies, the blood-brain tumor barrier-opening effects of PDE5 lasted considerably longer than those of bradykinin and allowed greater transport across the barrier into tumor tissues. Because vardenafil was found to be more effective than sildenafil in increasing blood-brain tumor barrier permeability and transport, vardenafil was used in a survival study of 29 tumor-bearing rats. Those treated with saline (control) survived 32 days on average while those treated with vardenafil alone survived about 35 days and those treated with adriamycin alone survived about 42 days. When vardenafil was combined with adriamycin, rats survived an average 53 days.

Although the researchers exposed the laboratory animals to doses of sildenafil and vardenafil that are comparable to the dose range approved for erectile dysfunction in humans, there were no detectable side effects in the rats, and neither drug increased transport of tracers into normal brain tissue.

Source: Cedars-Sinai Medical Center


Rank 1 /5 (1 vote)
Relevant PhysicsForums posts
  • Is Everyday Technology Killing Us?
    createdFeb 08, 2012
  • Exercise and weight loss
    createdFeb 08, 2012
  • Why do we have head aches? Our brains can't feel anything.
    createdFeb 07, 2012
  • "The end of diseases" by David Agus, interview from Daily Show with Jon Stewart
    createdFeb 04, 2012
  • Oncolytic adenovirus
    createdFeb 04, 2012
  • Nutrition label stuffs and diets
    createdFeb 02, 2012
  • More from Physics Forums - Medical Sciences

More news stories

Discovery paves way for salmonella vaccine

(Medical Xpress) -- An international research team led by a University of California, Davis, immunologist has taken an important step toward an effective vaccine against salmonella, a group of increasingly antibiotic-resistant ...

Medicine & Health / Research

created 42 minutes ago | popularity 5 / 5 (2) | comments 0 | with audio podcast

First-of-its-kind stem cell study re-grows healthy heart muscle in heart attack patients

Results from a Cedars-Sinai Heart Institute clinical trial show that treating heart attack patients with an infusion of their own heart-derived cells helps damaged hearts re-grow healthy muscle.

Medicine & Health / Cardiology

created 48 minutes ago | popularity 5 / 5 (1) | comments 2 | with audio podcast

Ovarian cancer arises in fallopian tube of knockout mice

(Medical Xpress) -- The most deadly form of "ovarian" cancer arises in the fallopian tubes – not the ovaries – of knockout mice that lack two genes associated with the disease, said researchers led by Baylor College ...

Medicine & Health / Cancer

created 43 minutes ago | popularity not rated yet | comments 0 | with audio podcast

Smoking bans lead to less, not more, smoking at home: study

Smoking bans in public/workplaces don't drive smokers to light up more at home, suggests a study of four European countries with smoke free legislation, published online in Tobacco Control.

Medicine & Health / Health

created 48 minutes ago | popularity not rated yet | comments 0

UK cases of progressive sight loss condition set to rise a third by 2020

New cases of the progressive sight loss condition, known as age-related macular degeneration, or AMD for short, are set to rise by a third in the UK over the next decade, reveals research published online in the British Jo ...

Medicine & Health / Diseases

created 47 minutes ago | popularity not rated yet | comments 0


Time of year important in projections of climate change effects on ecosystems

(PhysOrg.com) -- Does it matter whether long periods of hot weather, such as last year's heat wave that gripped the U.S. Midwest, happen in June or July, August or September?

Medical school link to wide variations in pass rate for specialist exam

Wide variations in doctors' pass rates, for a professional exam that is essential for one type of specialty training, seem to be linked to the particular medical school where the student graduated, indicates research published ...

Scientists discover reason for Mt. Hood's non-explosive nature

(PhysOrg.com) -- For a half-million years, Mount Hood has towered over the landscape, but unlike some of its cousins in Oregon’s Cascade Mountains and many other volcanoes around the Pacific “Rim ...

Missing dark matter located: Intergalactic space is filled with dark matter

Researchers at the University of Tokyo’s Institute for the Physics and Mathematics of the Universe (IPMU) and Nagoya University used large-scale computer simulations and recent observational data of gravitational ...

Plants use circadian rhythms to prepare for battle with insects

In a study of the molecular underpinnings of plants' pest resistance, Rice University biologists have shown that plants both anticipate daytime raids by hungry insects and make sophisticated preparations to ...

Sensing self and non-self: New research into immune tolerance

At the most basic level, the immune system must distinguish self from non-self, that is, it must discriminate between the molecular signatures of invading pathogens (non-self antigens) and cellular constituents that usually ...